GL1X · GenesisL1 explorer

Research workbench

Structure of anti-HCD33 conditional scfv with methotrexate

Analyse Structure of anti-HCD33 conditional scfv with methotrexate in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6UY3
Type
protein
Length
236 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti-CD33 conditional scfv
Ligands
MTX, PO4
Pockets
3 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAnti-CD33 conditional scfvprotein2364% helix, 49% strand—

Ligands and binding sites

  • MTX · Methotrexate · ligand · chains A
  • PO4 · Phosphate ion · ion · chains A
  • GOL · Glycerol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11140.600.8621MTX
21340.460.7724GOL
3870.330.7418empty

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6UY3 · Structure of anti-hCD33 conditional scFv with methotrexate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.